Seoul, South Korea

Mi Hyun Jang

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 1.4

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Mi Hyun Jang: Innovator in Oligonucleotide Technology

Introduction

Mi Hyun Jang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of oligonucleotide technology, holding a total of four patents. His work focuses on improving methods for predicting melting temperatures and optimizing combinations of oligonucleotides for various applications.

Latest Patents

One of Mi Hyun Jang's latest patents is a method for predicting the melting temperature of oligonucleotides. This invention relates specifically to primers or probes used in PCR or hybridization assays. The method allows for accurate predictions of melting temperatures in various reaction environments by utilizing optimized parameter values. Another notable patent involves methods for preparing optimal combinations of oligonucleotides. This invention introduces an innovative approach to optimize oligonucleotide combinations for detecting multiple target nucleic acid sequences, moving away from traditional empirical methods.

Career Highlights

Mi Hyun Jang is currently employed at Seegene, Inc., a company known for its advancements in molecular diagnostics. His work at Seegene has positioned him as a key player in the development of cutting-edge technologies in the field.

Collaborations

Some of Mi Hyun Jang's coworkers include Jong Yoon Chun and Han Bit Lee. Their collaborative efforts contribute to the innovative environment at Seegene, fostering advancements in oligonucleotide research.

Conclusion

Mi Hyun Jang's contributions to oligonucleotide technology through his patents and work at Seegene, Inc. highlight his role as a leading inventor in this specialized field. His innovative methods are paving the way for advancements in molecular diagnostics and related applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…